Success Metrics

Clinical Success Rate
88.1%

Based on 59 completed trials

Completion Rate
88%(59/67)
Active Trials
11(11%)
Results Posted
44%(26 trials)
Terminated
8(8%)

Phase Distribution

Ph early_phase_1
3
3%
Ph phase_4
32
31%
Ph phase_1
11
11%
Ph phase_3
23
22%
Ph phase_2
10
10%
Ph not_applicable
19
18%

Phase Distribution

14

Early Stage

10

Mid Stage

55

Late Stage

Phase Distribution98 total trials
Early Phase 1First-in-human
3(3.1%)
Phase 1Safety & dosage
11(11.2%)
Phase 2Efficacy & side effects
10(10.2%)
Phase 3Large-scale testing
23(23.5%)
Phase 4Post-market surveillance
32(32.7%)
N/ANon-phased studies
19(19.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.3%

59 of 70 finished

Non-Completion Rate

15.7%

11 ended early

Currently Active

11

trials recruiting

Total Trials

103

all time

Status Distribution
Active(13)
Completed(59)
Terminated(11)
Other(20)

Detailed Status

Completed59
unknown19
Recruiting10
Terminated8
Withdrawn3
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
103
Active
11
Success Rate
88.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (3.1%)
Phase 111 (11.2%)
Phase 210 (10.2%)
Phase 323 (23.5%)
Phase 432 (32.7%)
N/A19 (19.4%)

Trials by Status

unknown1918%
withdrawn33%
active_not_recruiting11%
completed5957%
not_yet_recruiting22%
suspended11%
recruiting1010%
terminated88%

Recent Activity

Clinical Trials (103)

Showing 20 of 103 trialsScroll for more
NCT07562282Not Applicable

Safety and Efficacy of Combination of Tamsulosin 0.4 mg Plus Tadalafil 5mg Versus 2.5 mg

Recruiting
NCT06257576Phase 3

Function of Tamsulosin in Older Males Undergoing Surgery With Indwelling Catheter

Completed
NCT04597372Phase 2

Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

Recruiting
NCT07467343Phase 4

Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover Trial

Not Yet Recruiting
NCT05657990Early Phase 1

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Recruiting
NCT07274228

Tamsulosin and the Risk of Serious Adverse Events

Completed
NCT02483793Not Applicable

Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population

Withdrawn
NCT06568718Not Applicable

Efficacy and Safety of Longidaze in the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

Completed
NCT07310797Phase 4

Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion

Not Yet Recruiting
NCT07307261Not Applicable

Evaluation of Mirabegron Versus Tamsulosin or Their Combination in Treatment of Lower Urinary Tract Symptoms

Completed
NCT05753670Phase 3

Effect of Preoperative Tamsulosin on Postoperative Urinary Retention

Completed
NCT07169773Not Applicable

Comparative Study Between Rezum and Tamsulosin

Completed
NCT06966804Phase 3

Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related Symptoms

Recruiting
NCT03808155Phase 4

Prevention of Postoperative Urinary Retention With Treatment of Tamsulosin 5 Days Prior to Lower Limb Arthroplasty

Completed
NCT05415748Phase 4

Deprescribing Tamsulosin in Older Men

Completed
NCT07114848Phase 4

Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ.

Completed
NCT06843538Phase 3

Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery

Recruiting
NCT05401032Phase 2

Proof-of-concept Study to Evaluate the Safety and Efficacy of Tryptophan in Patients with BPH.

Recruiting
NCT06754410Phase 3

Efficacy of Antihistamine Drugs as Medical Expulsive Therapy Alone or in Combination With Alpha Blockers: A Prospective Randomized Controlled Study

Completed
NCT06737016Phase 3

Efficacy and Safety of Tamsulosin for Children with Posterior Urethral Valve.

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
103